Clinical Trials List
2012-03-30 - 2014-06-30
Phase III
Terminated4
ICD-10F20.9
Schizophrenia, unspecified
ICD-9295.90
Unspecified schizophrenia, unspecified
A phase 3, Multicenter, Open-label trial to evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults with Schizophrenia
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
IQVIA Solutions Taiwan Ltd.
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林式穀 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林世祺 Division of Psychiatry
- 郭兆展 Division of Psychiatry
- mei feng Huang Division of Psychiatry
- 蔡冠逸 Division of Psychiatry
- 林世祺醫師 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
7 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
1000 participants
